Pedram Sendi holds an MD degree and a DMD degree from the University of Basel and a PhD in Health Economics from the Erasmus University in Rotterdam. He has conducted a number of applied studies on the cost-effectiveness of health care interventions such as in infectious diseases, HIV infection, obesity, diabetes, osteoporosis, hypertension, heart disease and dentistry. He has a particular interest in methodological issues related to cost-effectiveness analysis such as handling uncertainty and the decision rules of cost-effectiveness analysis. His current research focus is on methods to include risk-aversion in analysing and presenting the results of economic evaluations in health care.
Selected Publications
. (2021). Dealing with Bad Risk in Cost-Effectiveness Analysis: The Cost-Effectiveness Risk-Aversion Curve. PharmacoEconomics, 39(2), 161–169. https://doi.org/10.1007/s40273-020-00969-5
. (2021). Dealing with Bad Risk in Cost-Effectiveness Analysis: The Cost-Effectiveness Risk-Aversion Curve. PharmacoEconomics, 39(2), 161–169. https://doi.org/10.1007/s40273-020-00969-5
, Gafni A, Birch S, & Walter SD. (2021). Incorporating portfolio uncertainty in decision rules for healthcare resource allocation. Healthcare (Switzerland), 9(3). https://doi.org/10.3390/healthcare9030325
, Gafni A, Birch S, & Walter SD. (2021). Incorporating portfolio uncertainty in decision rules for healthcare resource allocation. Healthcare (Switzerland), 9(3). https://doi.org/10.3390/healthcare9030325
Gafni A., Walter S.D., Birch S., & (2008). An opportunity cost approach to sample size calculation in cost-effectiveness analysis. Health Economics, 17(1), 99–107. https://doi.org/10.1002/hec.1244
Gafni A., Walter S.D., Birch S., & (2008). An opportunity cost approach to sample size calculation in cost-effectiveness analysis. Health Economics, 17(1), 99–107. https://doi.org/10.1002/hec.1244
, & Brouwer WB. (2005). Is silence golden? A test of the incorporation of the effects of ill-health on income and leisure in health state valuations. Health economics, 14(6), 643–647. https://doi.org/10.1002/hec.971
, & Brouwer WB. (2005). Is silence golden? A test of the incorporation of the effects of ill-health on income and leisure in health state valuations. Health economics, 14(6), 643–647. https://doi.org/10.1002/hec.971
, Al, Maiwenn J, & Zimmermann, Heinz. (2004). A risk-adjusted approach to comparing the return on investment in health care programs. International Journal of Health Care Finance and Economics, 4(3), 199–210. https://doi.org/10.1023/b:ihfe.0000036046.80562.06
, Al, Maiwenn J, & Zimmermann, Heinz. (2004). A risk-adjusted approach to comparing the return on investment in health care programs. International Journal of Health Care Finance and Economics, 4(3), 199–210. https://doi.org/10.1023/b:ihfe.0000036046.80562.06
Craig BA, & . (2002). Estimation of the transition matrix of a discrete-time Markov chain. Health economics, 11(1), 33–42. https://doi.org/10.1002/hec.654
Craig BA, & . (2002). Estimation of the transition matrix of a discrete-time Markov chain. Health economics, 11(1), 33–42. https://doi.org/10.1002/hec.654
, Gafni A, & Birch S. (2002). Opportunity costs and uncertainty in the economic evaluation of health care interventions. Health economics, 11(1), 23–31. https://doi.org/10.1002/hec.641
, Gafni A, & Birch S. (2002). Opportunity costs and uncertainty in the economic evaluation of health care interventions. Health economics, 11(1), 23–31. https://doi.org/10.1002/hec.641
, & Briggs AH. (2001). Affordability and cost-effectiveness: decision-making on the cost-effectiveness plane. Health economics, 10(7), 675–680. https://doi.org/10.1002/hec.639
, & Briggs AH. (2001). Affordability and cost-effectiveness: decision-making on the cost-effectiveness plane. Health economics, 10(7), 675–680. https://doi.org/10.1002/hec.639